The CTTPA-G plusanti-PD-1 therapy inhibited the primary (Figure 6B) and distant (Figure 6C) tumor growth, resulting in a longer survivaltime (Figure 6D) ofB16F10 tumor-bearing mice. The gene discussed is PDCD1; the disease is neoplasm.